Review
Nature Reviews Immunology 7, 267-278 (April 2007) | doi:10.1038/nri2054
Scientific barriers to developing vaccines against avian influenza viruses
Kanta Subbarao1 & Tomy Joseph1 About the authors
Abstract
The increasing number of reports of direct transmission of avian influenza viruses to humans underscores the need for control strategies to prevent an influenza pandemic. Vaccination is the key strategy to prevent severe illness and death from pandemic influenza. Despite long-term experience with vaccines against human influenza viruses, researchers face several additional challenges in developing human vaccines against avian influenza viruses. In this Review, we discuss the features of avian influenza viruses, the gaps in our understanding of infections caused by these viruses in humans and of the immune response to them that distinguishes them from human influenza viruses, and the current status of vaccine development.
- View At a Glance
Author affiliations
- Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
Correspondence to: Kanta Subbarao1 Email: ksubbarao@niaid.nih.gov
Published online 16 March 2007
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Illuminating the switch in influenza virusesNature Biotechnology News and Views (01 Jan 2008)
Touching baseNature Genetics News and Views (01 Apr 2005)
See all 10 matches for News And ViewsRESEARCH
Combined therapeutic strategy using erythropoietin and mesenchymal stem cells potentiates neurogenesis after transient focal cerebral ischemia in ratsJournal of Cerebral Blood Flow & Metabolism Original Article
A GTP-binding adapter protein couples TRAIL receptors to apoptosis-inducing proteinsNature Immunology Article (01 Jun 2001)
See all 32 matches for Research
